The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C

Malte Bachmann1, Christian Kosan1, Pei Xiang Xing2, Mathias Montenarh3, Ingrid Hoffmann4, Tarik Möröy1
1Institut für Zellbiologie (Tumorforschung), IFZ, Universitätsklinikum Essen, Virchowstrasse 173, D-45122 Essen, Germany
2Austin Research Institute, Cancer Immunotherapy, Laboratory, Heidelberg, Vic. 3084, Australia
3Medizinische Biochemie und Molekularbiologie, Universität des Saarlandes, 66424 Homburg, Germany
4Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

Tài liệu tham khảo

Aho, 2004, Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser1 12 gatekeeper site, FEBS Lett., 571, 43, 10.1016/j.febslet.2004.06.050 Alevizos, 2001, Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis, Oncogene, 20, 6196, 10.1038/sj.onc.1204685 Allen, 1997, Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc, Oncogene, 15, 1133, 10.1038/sj.onc.1201288 Bachmann, 2004, The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): A novel role for Pim-1 at the G2/M cell cycle checkpoint, J. Biol. Chem., 279, 48319, 10.1074/jbc.M404440200 Bhattacharya, 2002, Pim-1 associates with protein complexes necessary for mitosis, Chromosoma, 111, 80, 10.1007/s00412-002-0192-6 Blomberg, 1999, Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases, Mol. Cell. Biol., 19, 6183, 10.1128/MCB.19.9.6183 Borg, 1999, Prolactin regulation of pim-1 expression: Positive and negative promoter elements, Endocrinology, 140, 5659, 10.1210/en.140.12.5659 Buckley, 1995, Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells, Endocrinology, 136, 5252, 10.1210/en.136.12.5252 Chen, 2002, Pim serine/threonine kinases regulate the stability of Socs-1 protein, Proc. Natl. Acad. Sci. U.S.A., 99, 2175, 10.1073/pnas.042035699 Cuypers, 1984, Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region, Cell, 37, 141, 10.1016/0092-8674(84)90309-X Dautry, 1988, Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines, J. Biol. Chem., 263, 17615, 10.1016/S0021-9258(19)77880-6 Dhanasekaran, 2001, Delineation of prognostic biomarkers in prostata cancer, Nature, 412, 822, 10.1038/35090585 Domen, 1993, Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells, Blood, 82, 1445, 10.1182/blood.V82.5.1445.1445 Domen, 1993, Analysis of Pim-1 function in mutant mice, Leukemia, 7, 108 Eichmann, 2000, Developmental expression of pim kinases suggests functions also outside of the hematopoietic system, Oncogene, 19, 1215, 10.1038/sj.onc.1203355 Friedmann, 1992, Characterization of the proto-oncogene pim-1: Kinase activity and substrate recognition sequence, Arch. Biochem. Biophys., 298, 594, 10.1016/0003-9861(92)90454-5 Graves, 2001, Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding, Oncogene, 20, 1839, 10.1038/sj.onc.1204259 Hassepass, 2004, Assaying Cdc25 phosphatase activity, Methods Mol. Biol., 281, 153 Ishibashi, 2001, Pim-1 translocates sorting nexin 6/TRAF4-associated factor 2 from cytoplasm to nucleus, FEBS Lett., 506, 33, 10.1016/S0014-5793(01)02881-2 Jaster, 1999, Interferon-alpha inhibits proliferation of Ba/F3 cells by interfering with interleukin-3 action, Cell Signal., 11, 769, 10.1016/S0898-6568(99)00050-9 Jaster, 1999, Role of STAT5 in interferon-alpha signal transduction in Ba/F3 cells, Cell Signal., 11, 331, 10.1016/S0898-6568(98)00049-7 Koike, 2000, Identification of heterochromatin protein 1 (HP1) as a phosphorylation target by Pim-1 kinase and the effect of phosphorylation on the transcriptional repression function of HP1, FEBS Lett., 467, 17, 10.1016/S0014-5793(00)01105-4 Krumenacker, 1998, Prolactin receptor signaling: Shared components with the T-cell antigen receptor in Nb2 lymphoma cells, Endocrine, 9, 163, 10.1385/ENDO:9:2:163 Laird, 1993, In vivo analysis of Pim-1 deficiency, Nucleic Acids Res., 21, 4750, 10.1093/nar/21.20.4750 Leverson, 1998, Pim-1 kinase and p100 cooperate to enhance c-Myb activity, Mol. Cell., 2, 417, 10.1016/S1097-2765(00)80141-0 Lilly, 1997, Enforced expression of the Mr 33 000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells, Cancer Res., 57, 5348 Lilly, 1999, The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway, Oncogene, 18, 4022, 10.1038/sj.onc.1202741 Maita, 2000, PAP-1, a novel target protein of phosphorylation by pim-1 kinase, Eur. J. Biochem., 267, 5168, 10.1046/j.1432-1327.2000.01585.x Margolis, 2003, PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation, EMBO J., 22, 5734, 10.1093/emboj/cdg545 Matikainen, 1999, Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells, Blood, 93, 1980, 10.1182/blood.V93.6.1980.406k20_1980_1991 Mochizuki, 1999, Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase Implications for the Pim-1-mediated activation of the c-Myc signalling pathway, J. Biol. Chem., 274, 18659, 10.1074/jbc.274.26.18659 Möröy, 1993, Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice, Proc. Natl. Acad. Sci. U.S.A., 90, 10734, 10.1073/pnas.90.22.10734 Mucenski, 1987, Common sites of viral integration in lymphomas arising in AKXD recombinant inbred mouse strains, Oncogene Res., 2, 33 Narimatsu, 2001, Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells, Mol. Cell. Biol., 21, 6615, 10.1128/MCB.21.19.6615-6625.2001 Nosaka, 1999, STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells, EMBO J., 18, 4754, 10.1093/emboj/18.17.4754 Padma, 1991, The human PIM-1 gene product is a protein serine kinase, Cancer Res., 51, 2486 Palaty, 1997, Phosphorylation site substrate specificity determinants for the Pim-1 protooncogene-encoded protein kinase, Biochem. Cell. Biol., 75, 153, 10.1139/o97-026 Palaty, 1997, Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 proto-oncogene-encoded protein kinase, J. Biol. Chem., 272, 10514, 10.1074/jbc.272.16.10514 Peltola, 2004, Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3, Blood, 103, 3744, 10.1182/blood-2003-09-3126 Peng, 1998, C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding, Cell Growth Differ., 9, 197 Pircher, 2000, Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death, Oncogene, 19, 3684, 10.1038/sj.onc.1203684 Qian, 2001, The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes, Mol. Biol. Cell., 12, 1791, 10.1091/mbc.12.6.1791 Rainio, 2002, Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase, J. Immunol., 168, 1524, 10.4049/jimmunol.168.4.1524 Roshak, 2000, The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase, Cell Signal., 405, 10.1016/S0898-6568(00)00080-2 Saris, 1991, The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG, EMBO J., 10, 655, 10.1002/j.1460-2075.1991.tb07994.x Selten, 1985, Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas, EMBO J., 4, 1793, 10.1002/j.1460-2075.1985.tb03852.x Shirogane, 1999, Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis, Immunity, 11, 709, 10.1016/S1074-7613(00)80145-4 Takizawa, 2000, Control of mitosis by changes in the subcellular location of cyclin-B 1-Cdk1 and Cdc25C, Curr. Opin. Cell. Biol., 12, 658, 10.1016/S0955-0674(00)00149-6 van der Lugt, 1995, Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2, EMBO J., 14, 2536, 10.1002/j.1460-2075.1995.tb07251.x van Lohuizen, 1989, Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors, Cell, 56, 673, 10.1016/0092-8674(89)90589-8 Wang, 2001, Pim-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells, Arch. Biochem. Biophys., 39, 9, 10.1006/abbi.2001.2370 Wang, 2002, Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase, Biochim. Biophys. Acta, 1593, 45, 10.1016/S0167-4889(02)00347-6 Winn, 2003, Pim-1 phosphorylates the DNA binding domain of c-Myb, Cell Cycle, 2, 258, 10.4161/cc.2.3.383 Yan, 2003, The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death, J. Biol. Chem., 278, 45358, 10.1074/jbc.M307933200 Zörnig, 1996, Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2, Oncogene, 12, 1789